- Home
- EEA vs ZYXI Comparison
EEA vs ZYXI Comparison
Compare EEA & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- ZYXI
- Stock Information
- Founded
- EEA 1986
- ZYXI 1996
- Country
- EEA Germany
- ZYXI United States
- Employees
- EEA N/A
- ZYXI N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EEA Finance
- ZYXI Health Care
- Exchange
- EEA Nasdaq
- ZYXI Nasdaq
- Market Cap
- EEA 66.7M
- ZYXI 72.3M
- IPO Year
- EEA N/A
- ZYXI N/A
- Fundamental
- Price
- EEA $10.19
- ZYXI $2.68
- Analyst Decision
- EEA
- ZYXI Buy
- Analyst Count
- EEA 0
- ZYXI 3
- Target Price
- EEA N/A
- ZYXI $6.00
- AVG Volume (30 Days)
- EEA 9.2K
- ZYXI 291.0K
- Earning Date
- EEA 01-01-0001
- ZYXI 07-24-2025
- Dividend Yield
- EEA 1.92%
- ZYXI N/A
- EPS Growth
- EEA N/A
- ZYXI N/A
- EPS
- EEA N/A
- ZYXI N/A
- Revenue
- EEA N/A
- ZYXI $172,401,000.00
- Revenue This Year
- EEA N/A
- ZYXI N/A
- Revenue Next Year
- EEA N/A
- ZYXI $19.55
- P/E Ratio
- EEA N/A
- ZYXI N/A
- Revenue Growth
- EEA N/A
- ZYXI N/A
- 52 Week Low
- EEA $7.45
- ZYXI $1.66
- 52 Week High
- EEA $9.26
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- EEA 71.33
- ZYXI 56.72
- Support Level
- EEA $9.85
- ZYXI $2.30
- Resistance Level
- EEA $10.18
- ZYXI $2.82
- Average True Range (ATR)
- EEA 0.11
- ZYXI 0.18
- MACD
- EEA 0.01
- ZYXI 0.04
- Stochastic Oscillator
- EEA 97.58
- ZYXI 65.66
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.